Identification of capsular types in carbapenem-resistant klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 1038-1047

  Pan, Yi Jiun ^a   Lin, Tzu Lung ^a   Lin, Yi Tsung ^b   Su, Po An ^a   Chen, Chun Tang ^a   Hsieh, Pei Fang ^a   Hsu, Chun Ru ^a   Chen, Ching Ching ^a   Hsieh, Yu Chia ^c   Wang, Jin Town ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; AMINOGLYCOSIDE; CARBAPENEM; CARBAPENEMASE; CYCLOPHOSPHAMIDE; DIHYDROFOLATE REDUCTASE; ENDOTOXIN; PENICILLINASE; RIFAMPICIN; ANTIINFECTIVE AGENT; CAPSULAR-POLYSACCHARIDE GALACTOHYDROLASE; CARBAPENEM DERIVATIVE; GLYCOSIDASE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CAPSULE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM IDENTIFICATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CONTROLLED STUDY; FEMALE; GENE CASSETTE; GENE CLUSTER; GENE SEQUENCE; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; INOCULATION; INTEGRON; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETHAL DOSE; LEUKOCYTE; MOUSE; MULTILOCUS SEQUENCE TYPING; NEIGHBOR JOINING METHOD; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SURVIVAL RATE; WZC GENE; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL CAPSULES; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GLYCOSIDE HYDROLASES; HUMANS; KLEBSIELLA PNEUMONIAE; MICE; MICE, INBRED BALB C;

EID: 84921896304     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03560-14     Document Type: Article

References (59)

1. Abbot SL. 2003. Klebsiella, Enterobacter, Citrobacter, Serratia, Plesiomonas, and other Enterobacteriaceae, p 684-700. In Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (ed), Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
2. Lin YT, Jeng YY, Chen TL, Fung CP. 2010. Bacteremic communityacquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis 10:307. http://dx.doi.org/10.1186/1471-2334-10-307.
3. Tsai FC, Huang YT, Chang LY, Wang JT. 2008. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis 14:1592-1600. http://dx.doi .org/10.3201/eid1410.071254.
4. Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanes C. 2001. SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob Agents Chemother 45: 2856-2861. http://dx.doi.org/10.1128/AAC.45.10.2856-2861.2001.
5. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317. http://dx.doi.org/10.1007/BF01641355.
6. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302-306.
7. Bauernfeind A, Grimm H, Schweighart S. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298. http: //dx.doi.org/10.1007/BF01647010.
8. Chong Y, Yakushiji H, Ito Y, Kamimura T. 2011. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 30:83-87. http://dx.doi.org/10.1007/s10096-010 -1057-1.
9. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ. 2007. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60:1018-1029. http: //dx.doi.org/10.1093/jac/dkm310.
10. Srinivasan A, Patel JB. 2008. Klebsiella pneumoniae carbapenemaseproducing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 29:1107-1109. http://dx.doi.org/10 .1086/594129.
11. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29:996-1011. http://dx.doi.org/10.1086/591861.
12. Sisto A, D'Ancona F, Meledandri M, Pantosti A, Rossolini GM, Raglio A, Serra R, Dematte L, Aiello E, Goglio A. 2012. Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012. Euro Surveill 17(33) :pii =20247. http://www.eurosurveillance.org /ViewArticle.aspx?ArticleId -20247.
13. Kaohsiung Medical University Hospital. 2011. Annual report of Taiwan Nosocomial Infection Surveillance Systems. Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. http://www.kmuh.org.tw/info/admin /actboard/data/20125112222508.pdf.
14. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob Agents Chemother 48:1503-1508. http://dx .doi.org/10.1128/AAC.48.5.1503-1508.2004.
15. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2005. Treatment of experimental Escherichia coli infection with recombinant bacteriophagederived capsule depolymerase. J Antimicrob Chemother 56:160-165. http://dx.doi.org/10.1093/jac/dki177.
16. Scorpio A, Chabot DJ, Day WA, O'Brien DK, Vietri NJ, Itoh Y, Mohamadzadeh M, Friedlander AM. 2007. Poly-γ-glutamate capsuledegrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis. Antimicrob Agents Chemother 51:215-222. http://dx.doi.org/10.1128/AAC.00706-06.
17. Scorpio A, Tobery SA, Ribot WJ, Friedlander AM. 2008. Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrob Agents Chemother 52:1014-1020. http://dx.doi.org/10.1128/AAC .00741-07.
18. Scorpio A, Chabot DJ, Day WA, Hoover TA, Friedlander AM. 2010. Capsule depolymerase overexpression reduces Bacillus anthracis virulence. Microbiology 156:1459-1467. http://dx.doi.org/10.1099/mic.0 .035857-0.
19. Bansal S, Harjai K, Chhibber S. 2014. Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection. BMC Infect Dis 14:456. http://dx.doi.org/10.1186/1471-2334-14-456.
20. Lin TL, Hsieh PF, Huang YT, Lee WC, Tsai YT, Su PA, Pan YJ, Hsu CR, Wu MC, Wang JT. 2014. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis 210:1734-1744. http://dx.doi.org/10 .1093/infdis/jiu332.
21. Tsay RW, Siu LK, Fung CP, Chang FY. 2002. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 162:1021-1027. http://dx.doi.org/10.1001/archinte.162.9.1021.
22. Kubler-Kielb J, Vinogradov E, Ng WI, Maczynska B, Junka A, Bartoszewicz M, Zelazny A, Bennett J, Schneerson R. 2013. The capsular polysaccharide and lipopolysaccharide structures of two carbapenem resistant Klebsiella pneumoniae outbreak isolates. Carbohydr Res 369:6-9. http://dx.doi.org/10.1016/j.carres.2012.12.018.
23. D'Andrea MM, Amisano F, Giani T, Conte V, Ciacci N, Ambretti S, Santoriello L, Rossolini GM. 2014. Diversity of capsular polysaccharide gene clusters in Kpc-producing Klebsiella pneumoniae clinical isolates of sequence type 258 involved in the Italian epidemic. PLoS One 9:e96827. http://dx.doi.org/10.1371/journal.pone.0096827.
24. Diago-Navarro E, Chen L, Passet V, Burack S, Ulacia-Hernando A, Kodiyanplakkal RP, Levi MH, Brisse S, Kreiswirth BN, Fries BC. 2014. Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. J Infect Dis 210: 803-813. http://dx.doi.org/10.1093/infdis/jiu157.
25. Chen L, Chavda KD, Findlay J, Peirano G, Hopkins K, Pitout JD, Bonomo RA, Woodford N, DeLeo FR, Kreiswirth BN. 2014. Multiplex PCR for identification of two capsular types in epidemic KPC-producing Klebsiella pneumoniae sequence type 258 strains. Antimicrob Agents Chemother 58:4196-4199. http://dx.doi.org/10.1128/AAC.02673-14.
26. Chen L, Mathema B, Pitout JD, DeLeo FR, Kreiswirth BN. 2014. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 5(3): e01355-14. http://dx.doi.org/10.1128/mBio.01355-14.
27. Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, Chavda KD, Jacobs MR, Mathema B, Olsen RJ, Bonomo RA, Musser JM, Kreiswirth BN. 2014. Molecular dissection of the evolution of car-bapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A 111:4988-4993. http://dx.doi.org/10.1073/pnas .1321364111.
28. Hsu CR, Lin TL, Pan YJ, Hsieh PF, Wang JT. 2013. Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. PLoS One 8:e70092. http://dx.doi.org/10.1371/journal.pone.0070092.
29. Pan YJ, Fang HC, Yang HC, Lin TL, Hsieh PF, Tsai FC, Keynan Y, Wang JT. 2008. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol 46:2231-2240. http://dx.doi.org/10.1128/JCM.01716-07.
30. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
31. Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. 2006. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 50:3396-3406. http://dx.doi .org/10.1128/AAC.00285-06.
32. Grobner S, Linke D, Schutz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y. 2009. Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol 58:912-922. http://dx.doi.org/10.1099/jmm.0.005850-0.
33. Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S. 2012. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 67:906-909. http://dx.doi.org/10.1093/jac/dkr563.
34. Bhattacharya D, Thamizhmani R, Bhattacharya H, Sayi DS, Muruganandam N, Roy S, Sugunan AP. 2013. Emergence of New Delhi metallo-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India. Microb Drug Resist 19:457-462. http://dx.doi.org/10.1089/mdr.2013.0070.
35. Lin TL, Tang SI, Fang CT, Hsueh PR, Chang SC, Wang JT. 2006. Extended-spectrum β-lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization of shv-27, shv-41, and tem-116. Microb Drug Resist 12:12-15. http://dx.doi.org/10.1089/mdr.2006.12.12.
36. Pellegrini C, Celenza G, Segatore B, Bellio P, Setacci D, Amicosante G, Perilli M. 2011. Occurrence of class 1 and 2 integrons in resistant Enterobacteriaceae collected from a urban wastewater treatment plant: first report from central Italy. Microb Drug Resist 17:229-234. http://dx.doi.org /10.1089/mdr.2010.0117.
37. Nordmann P, Poirel L, Dortet L. 2012. Rapid detection of carbapen-emase-producing Enterobacteriaceae. Emerg Infect Dis 18:1503-1507. http://dx.doi.org/10.3201/eid1809.120355.
38. D'Agata EM, Gerrits MM, Tang YW, Samore M, Kusters JG. 2001. Comparison of pulsed-field gel electrophoresis and amplified fragmentlength polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 22:550-554. http://dx .doi.org/10.1086/501950.
39. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239.
40. Pan YJ, Lin TL, Chen YH, Hsu CR, Hsieh PF, Wu MC, Wang JT. 2013. Capsular types of Klebsiella pneumoniae revisited by wzc sequencing. PLoS One 8:e80670. http://dx.doi.org/10.1371/journal.pone.0080670.
41. Pieroni P. 1996. Application of bacteriophage typing to Klebsiella pneumoniae. Saskatchewan University, Saskatoon, Canada.
42. Chuang YP, Fang CT, Lai SY, Chang SC, Wang JT. 2006. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 193:645-654. http://dx.doi.org /10.1086/499968.
43. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 199:697-705. http: //dx.doi.org/10.1084/jem.20030857.
44. Pan YJ, Lin TL, Hsu CR, Wang JT. 2011. Use of a Dictyostelium model for isolation of genetic loci associated with phagocytosis and virulence in Klebsiella pneumoniae. Infect Immun 79:997-1006. http://dx.doi.org/10 .1128/IAI.00906-10.
45. Reyes A, Bello H, Dominguez M, Mella S, Zemelman R, Gonzalez G. 2003. Prevalence and types of class 1 integrons in aminoglycosideresistant Enterobacteriaceae from several Chilean hospitals. J Antimicrob Chemother 51:317-321. http://dx.doi.org/10.1093/jac/dkg083.
46. Cortes G, Borrell N, de Astorza B, Gomez C, Sauleda J, Alberti S. 2002. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70:2583-2590. http://dx.doi.org/10.1128/IAI.70.5.2583-2590.2002.
47. Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, Siu LK. 2002. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50:420-424. http://dx.doi.org/10.1136/gut.50.3.420.
48. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC. 2008. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 62:1-6. http://dx.doi.org/10.1016/j .diagmicrobio.2008.04.007.
49. Cryz SJ, Jr, Mortimer PM, Mansfield V, Germanier R. 1986. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 23:687-690.
50. Jenney AW, Clements A, Farn JL, Wijburg OL, McGlinchey A, Spelman DW, Pitt TL, Kaufmann ME, Liolios L, Moloney MB, Wesselingh SL, Strugnell RA. 2006. Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol 44:102-107. http://dx.doi.org/10.1128/JCM.44.1.102 -107.2006.
51. Brisse S, Issenhuth-Jeanjean S, Grimont PA. 2004. Molecular serotyping of Klebsiella species isolates by restriction of the amplified capsular antigen gene cluster. J Clin Microbiol 42:3388-3398. http://dx.doi.org/10.1128 /JCM.42.8.3388-3398.2004.
52. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, Gales AC, Venezia SN, Quinn JP, Nordmann P. 2010. Worldwide diversity of Klebsiella pneumoniae that produce β-lactamase blaKPC-2 gene. Emerg Infect Dis 16:1349-1356. http://dx.doi.org/10.3201/eid1609.091389.
53. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, Song JH, Ko KS. 2010. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother 54:2278-2279. http://dx.doi.org/10.1128/AAC.00011-10.
54. Lee MY, Ko KS, Kang CI, Chung DR, Peck KR, Song JH. 2011. High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 38:160-163. http://dx.doi.org/10.1016/j.ijantimicag.2011.03.020.
55. Ma L, Lu PL, Siu LK, Hsieh MH. 2013. Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J Med Microbiol 62:101-107. http://dx.doi.org/10.1099 /jmm.0.050492-0.
56. Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, Wang JT, Wang LS, Siu LK, Yeh KM. 2013. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One 8:e69428. http: //dx.doi.org/10.1371/journal.pone.0069428.
57. Garcia-Sureda L, Domenech-Sanchez A, Barbier M, Juan C, Gasco J, Alberti S. 2011. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 55: 4742-4747. http://dx.doi.org/10.1128/AAC.00309-11.
58. Rieger-Hug D, Stirm S. 1981. Comparative study of host capsule depolymerases associated with Klebsiella bacteriophages. Virology 113:363-378. http://dx.doi.org/10.1016/0042-6822(81)90162-8.
59. Reichelt P, Schwarz C, Donzeau M. 2006. Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expr Purif 46:483-488. http://dx.doi.org/10.1016/j.pep.2005.09.027.